Insight Molecular Diagnostics (IMDX) Non Operating Income (2015 - 2026)
Insight Molecular Diagnostics (IMDX) posted Non Operating Income of $123000.0 for Q1 2026, down 74.38% sequentially from $480000.0 in Q4 2025, and down 3.91% YoY from $128000.0 in Q1 2025.
Insight Molecular Diagnostics (IMDX) Non Operating Income (2015 - 2026) Analysis & Trends
Insight Molecular Diagnostics has reported Non Operating Income for 12 years, with the latest figure at $123000.0 in Q1 2026.
- Quarterly Non Operating Income fell 3.91% year-over-year to $123000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $897000.0 (up 143.75% YoY) and the FY2025 annual result came in at $902000.0, up 138.62% from the prior year.
- Non Operating Income slipped to $123000.0 in Q1 2026 per IMDX's latest filing, from $480000.0 in the prior quarter.
- Over five years, Non Operating Income peaked at $480000.0 in Q4 2025 and troughed at -$396000.0 in Q1 2022.
- A 5-year average of $62882.4 and a median of $109000.0 in 2023 frame the typical range for Non Operating Income.
- The sharpest annual moves came in 2022 and 2025: Non Operating Income slumped 241.67% in 2022, then soared 781.82% in 2025.
- Over 5 years, Non Operating Income stood at -$369000.0 in 2022, then soared by 150.68% to $187000.0 in 2023, then sank by 37.97% to $116000.0 in 2024, then surged by 313.79% to $480000.0 in 2025, then sank by 74.38% to $123000.0 in 2026.
- According to Business Quant data, Non Operating Income over the past three periods registered $123000.0, $480000.0, and $194000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | - |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | - |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | - |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | - |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | - |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 15.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | - |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | - |
| 10 | Insight Molecular Diagnostics | 158.03 Mn | 139.50 Mn | 157,000.00 | 142,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 142,000.00 |
| Mar 31, 2026 | 123,000.00 |
| Dec 31, 2025 | 480,000.00 |
| Sep 30, 2025 | 194,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 128,000.00 |
| Dec 31, 2024 | 116,000.00 |
| Sep 30, 2024 | 22,000.00 |
| Jun 30, 2024 | 102,000.00 |
| Mar 31, 2024 | 138,000.00 |
| Dec 31, 2023 | 187,000.00 |
| Sep 30, 2023 | 24,000.00 |
| Jun 30, 2023 | -39,000.00 |
| Mar 31, 2023 | 109,000.00 |
| Dec 31, 2022 | -369,000.00 |
| Sep 30, 2022 | -112,000.00 |
| Jun 30, 2022 | 262,000.00 |
| Mar 31, 2022 | -396,000.00 |
| Dec 31, 2021 | -108,000.00 |
| Sep 30, 2021 | -196,000.00 |